Recall of losartan potassium tablets USP and losartan potassium/hydrochlorothiazide tablets USP by Torrent Pharmaceuticals due to detection of n-methylnitrosobutyric acid (NMBA).
Medications used to treat hepatitis C virus (HCV) infections containing protease inhibitors can cause further liver dysfunction in patients with liver impairment.
Recall of bevacizumab 1.25 mg/0.05 mL 31G injectable and bevacizumab 2.5 mg/0.1 mL normject TB injectable by Pacifico National dba AmEx Pharmacy due to risk of infection.